ResearcherIndraprastha Institute of Information Technology DelhiActive in the last 2 years
Gajendra P. S. Raghava
Matched on ORCID iD 0000-0002-8902-2876; OpenAlex author ID A5051938893.
Their work
- Papers
- 6 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 4
2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- A large language model for predicting pancreatic ductal adenocarcinoma patients from blood-derived exosomal transcriptomics data Last author DOI 10.1101/2025.03.06.641795↗
- Prediction of pancreatic adenocarcinoma patient risk status using alternative splicing events Last author DOI 10.1101/2021.06.02.446780↗
- Prediction of pancreatic adenocarcinoma patient risk status using alternative splicing events Last author DOI 10.21203/rs.3.rs-411576/v1↗
- In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma. Last author DOI 10.3390/ijms20143582↗
- PCMdb: pancreatic cancer methylation database. Last author DOI 10.1038/srep04197↗
- Designing of promiscuous inhibitors against pancreatic cancer cell lines. Last author DOI 10.1038/srep04668↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Rajesh Kumar · 3 shared papers, 2019–2021
- Paper Prediction of pancreatic adenocarcinoma patient risk status using alternative splicing events DOI 10.1101/2021.06.02.446780↗
- Paper Prediction of pancreatic adenocarcinoma patient risk status using alternative splicing events DOI 10.21203/rs.3.rs-411576/v1↗
- Paper In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma. DOI 10.3390/ijms20143582↗
- Shubham Choudhury · 1 shared paper, 2025
- Gandharva Nagpal · 2 shared papers, 2014–2019
- Rahul Kumar · 1 shared paper, 2014
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.